PERFALGAN 10 mg/ml, solution for infusion - Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 08/07/2010

 

Problem Or Issue:
Important safety information communication from Bristol-Myers Squibb Pharmaceuticals on serious cases of overdose reported in infants and children with PERFALGAN® 10 mg/ml, solution for infusion.

Important Safety Information - PERFALGAN 10 mg/ml, solution for infusion


« Back